These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3780720)

  • 1. Specificity of human glucosylceramide beta-glucosidase towards synthetic glucosylsphingolipids inserted into liposomes. Kinetic studies in a detergent-free assay system.
    Sarmientos F; Schwarzmann G; Sandhoff K
    Eur J Biochem; 1986 Nov; 160(3):527-35. PubMed ID: 3780720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between the activity of glucosylceramidase and its binding to glucosylceramide-containing liposomes. Role of acidic phospholipids and fatty acids.
    Vaccaro AM; Tatti M; Salvioli R; Ciaffoni F; Gallozzi E
    Biochim Biophys Acta; 1990 Jan; 1033(1):73-9. PubMed ID: 2302413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding of glucosylceramidase to glucosylceramide is promoted by its activator protein.
    Vaccaro AM; Muscillo M; Salvioli R; Tatti M; Gallozzi E; Suzuki K
    FEBS Lett; 1987 Jun; 216(2):190-4. PubMed ID: 3582671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of synthetic and natural glucosylceramides as substrate for glucosylceramidase assay.
    Vaccaro AM; Kobayashi T; Suzuki K
    Clin Chim Acta; 1982 Jan; 118(1):1-7. PubMed ID: 7053901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of saposins A and C on the enzymatic hydrolysis of liposomal glucosylceramide.
    Vaccaro AM; Tatti M; Ciaffoni F; Salvioli R; Barca A; Scerch C
    J Biol Chem; 1997 Jul; 272(27):16862-7. PubMed ID: 9201993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal degradation on vesicular membrane surfaces. Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators.
    Wilkening G; Linke T; Sandhoff K
    J Biol Chem; 1998 Nov; 273(46):30271-8. PubMed ID: 9804787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human lysosomal beta-glucosidase: kinetic characterization of the catalytic, aglycon, and hydrophobic binding sites.
    Grabowski GA; Gatt S; Kruse J; Desnick RJ
    Arch Biochem Biophys; 1984 May; 231(1):144-57. PubMed ID: 6426391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hydrogenation of glucosyl- and galactosylceramide on their enzymatic hydrolysis.
    Vaccaro AM; Muscillo M; Suzuki K
    Clin Chim Acta; 1983 Jun; 131(1-2):1-13. PubMed ID: 6883703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a heat-stable factor in human placenta on glucosylceramidase, glucosylsphingosine glucosyl hydrolase, and acid beta-glucosidase activities.
    Vaccaro AM; Muscillo M; Tatti M; Salvioli R; Gallozzi E; Suzuki K
    Clin Biochem; 1987 Dec; 20(6):429-33. PubMed ID: 3124976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of activator proteins for the enzymatic degradation of glucosylceramide in several human tissues.
    Vaccaro AM; Ciaffoni F; Mandara I; Suzuki K
    Clin Chim Acta; 1988 Mar; 172(2-3):323-34. PubMed ID: 3370844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of human glucosylsphingosine glucosyl hydrolase and comparison with glucosylceramidase.
    Vaccaro AM; Muscillo M; Suzuki K
    Eur J Biochem; 1985 Jan; 146(2):315-21. PubMed ID: 3967661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake by neuroblastoma cells of glucosylceramide, glucosylceramide glucosidase, its stimulator protein, and phosphatidylserine.
    Datta SC; Snider RM; Radin NS
    Biochim Biophys Acta; 1986 Jul; 877(3):387-98. PubMed ID: 3730407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of short-chain ceramide and dihydroceramide analogues in Chinese hamster ovary (CHO) cells.
    Ridgway ND; Merriam DL
    Biochim Biophys Acta; 1995 Apr; 1256(1):57-70. PubMed ID: 7742357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An endogenous activator protein in human placenta for enzymatic degradation of glucosylceramide.
    Vaccaro AM; Muscillo M; Gallozzi E; Salvioli R; Tatti M; Suzuki K
    Biochim Biophys Acta; 1985 Sep; 836(2):157-66. PubMed ID: 4027262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct evidence by carbon-13 NMR spectroscopy for the erythro configuration of the sphingoid moiety in Gaucher cerebroside and other natural sphingolipids.
    Sarmientos F; Schwarzmann G; Sandhoff K
    Eur J Biochem; 1985 Jan; 146(1):59-64. PubMed ID: 3967657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The assay of glucocerebrosidase activity using the natural substrata.
    Strasberg PM; Lowden JA
    Clin Chim Acta; 1982 Jan; 118(1):9-20. PubMed ID: 7053909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human acid beta-glucosidase: use of inhibitors, alternative substrates and amphiphiles to investigate the properties of the normal and Gaucher disease active sites.
    Osiecki-Newman K; Fabbro D; Legler G; Desnick RJ; Grabowski GA
    Biochim Biophys Acta; 1987 Sep; 915(1):87-100. PubMed ID: 2956992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrolysis of lactosylceramide by human galactosylceramidase and GM1-beta-galactosidase in a detergent-free system and its stimulation by sphingolipid activator proteins, sap-B and sap-C. Activator proteins stimulate lactosylceramide hydrolysis.
    Zschoche A; Fürst W; Schwarzmann G; Sanhoff K
    Eur J Biochem; 1994 May; 222(1):83-90. PubMed ID: 8200356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human acid beta-glucosidase: use of sphingosyl and N-alkyl-glucosylamine inhibitors to investigate the properties of the active site.
    Greenberg P; Merrill AH; Liotta DC; Grabowski GA
    Biochim Biophys Acta; 1990 May; 1039(1):12-20. PubMed ID: 2141287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fate of glucosylceramide (glucocerebroside) in genetically impaired (lysosomal beta-glucosidase deficient) Gaucher disease diploid human fibroblasts.
    Saito M; Rosenberg A
    J Biol Chem; 1985 Feb; 260(4):2295-300. PubMed ID: 3919000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.